A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable AnginaChristopher Rajkumar, Rasha Al‐Lamee, Ramzi Khamis et al.|New England Journal of Medicine|2023Cited by 223
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trialMichael Foley, Rasha Al‐Lamee, Christopher Rajkumar et al.|The Lancet|2024Cited by 86
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery DiseaseFlorentina Simader, Amit Kaura, Christopher Rajkumar et al.|Journal of the American College of Cardiology|2024Cited by 36
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery DiseaseMichael Foley, Christopher Rajkumar, Fiyyaz Ahmed‐Jushuf et al.|Circulation|2024Cited by 19
N-of-1 Trial of Angina Verification Before Percutaneous Coronary InterventionChristopher Rajkumar, Rasha Al‐Lamee, Michael Foley et al.|Journal of the American College of Cardiology|2024Cited by 18